Brief: Medesis Pharma Issues Bond Financing With Maximum Potential Nominal Amount Of EUR 2.5 Mln

Medesis Pharma SA

31/03/2023 07:14

March 31 (Reuters) - Medesis Pharma SA  ALMDP.PA :
    * MEDESIS PHARMA SETS UP A BOND FINANCING WITH A MAXIMUM
POTENTIAL
NOMINAL AMOUNT OF €2,500,000
    * THE TOTAL AMOUNT OF THE ISSUE ALLOWS MEDESIS PHARMA TO
EXTEND
ITS CASH FLOW HORIZON UNTIL THE END OF 2023
    * THE SUBSCRIPTION OF THESE OCAS IS RESERVED FOR THE
INVESTMENT
COMPANY NICE & GREEN SA, A COMPANY UNDER SWISS LAW
    * THE OCAS, WITH A NOMINAL VALUE OF EUR 10,000, HAVE A
MATURITY OF
18 MONTHS AND WILL NOT GIVE RISE TO THE PAYMENT OF INTEREST
    * ON THE BASIS OF THE CURRENT SHARE PRICE, I.E. €2.8066 IN
THE
EVENT OF THE DRAWING AND CONVERSION OF ALL 270 OCAS, THE TOTAL
DILUTION INDUCED IS 23.84%


Further company coverage:  ALMDP.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48587696600;))